{
  "ptid_time": "024_S_4186_2011-09-02",
  "img_path": "/data/qiuhui/data/adni/images/024_S_4186/2011-09-02/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 80,393 mm³, 108.7% above the reference mean. With a Z-score of 2.60 (99.5th percentile), this represents significant enlargement; hippocampal volume measures 5,651 mm³, 25.2% below the reference mean. With a Z-score of -2.46 (0.7th percentile), this represents significant atrophy; whole brain volume measures 1,147,380 mm³, 6.3% above the reference mean. With a Z-score of 0.82 (79.3th percentile), this represents normal volume ; entorhinal cortex volume measures 2,670 mm³, 34.9% below the reference mean. With a Z-score of -2.37 (0.9th percentile), this represents significant atrophy; fusiform gyrus volume measures 20,343 mm³, 8.0% above the reference mean. With a Z-score of 0.68 (75.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,539 mm³, 5.6% above the reference mean. With a Z-score of 0.51 (69.3th percentile), this represents normal volume . ",
  "text_data": "Age is 74.4 years. Gender is Male. Education: 12 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Dermatologic-Connective Tissue; Musculoskeletal; Gastrointestinal; Hematopoietic-Lymphatic; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 30.0. MoCA: 22.0. Logical Memory: 8.0. Laboratory findings: Eosinophils: 0.58 (profound elevated); Eosinophils: 9.00 (profound elevated). APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 1226.00 pg/mL (normal ); Total tau: 150.50 pg/mL (mild reduced); Phosphorylated tau: 12.05 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant hippocampal and entorhinal cortex atrophy, which are hallmark features of Alzheimer's disease (AD), along with ventricular enlargement suggesting neurodegeneration. However, the MMSE is normal (30/30), while the MoCA (22/30) suggests mild cognitive impairment (MCI), and biomarkers (Aβ normal, reduced tau) do not strongly support AD pathology.  \n\n**Diagnosis:** **MCI** (likely non-AD etiology given biomarker profile)  \n**Confidence:** **Medium** (conflicting cognitive scores and atypical biomarkers, but structural atrophy is concerning)",
  "timestamp": "2025-07-26T03:19:39.256062"
}